Financial Summary (All financials)
| In millions, except per share items | Dec-31-18 | Dec-31-17 | Dec-31-16 | Dec-31-15 |
| Revenues | 0.0 | 0.0 | 0.0 | 35.9 |
| Revenue growth | | | -100.0% | |
| Cost of goods sold | 19.1 | 20.0 | 14.4 | 29.9 |
| Gross profit | -19.1 | -20.0 | -14.4 | 6.0 |
| Gross margin | | | | 16.6% |
| Selling, general and administrative | 11.6 | 13.6 | 10.8 | 10.2 |
| Research and development | 7.5 | 6.4 | 3.6 | 4.1 |
| EBIT | 0.0 | 0.0 | 0.0 | -8.3 |
| EBIT margin | | | | -23.1% |
| Pre-tax income | 0.0 | 0.0 | 0.0 | -11.4 |
| Income taxes | 0.0 | 0.0 | 0.0 | 0.0 |
| Tax rate | | | | 0.0% |
| Net income | 0.0 | 0.0 | 0.0 | -11.4 |
| Net margin | | | | -31.9% |
| |
| Diluted EPS | | | | ($1.12) |
| Shares outstanding (diluted) | | | | 10.2 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|